R11	PredicateNominative Attribute:T37 Head:T35
R12	PredicateNominative Attribute:T42 Head:T10
R13	PredicateNominative Attribute:T58 Head:T18
R14	Anaphora Anaphor:T45 Antecedent:T11
R15	Anaphora Anaphor:T56 Antecedent:T16
R16	Anaphora Anaphor:T57 Antecedent:T56
R17	Anaphora Anaphor:T59 Antecedent:T18
R18	Anaphora Anaphor:T75 Antecedent:T4
R19	Anaphora Anaphor:T75 Antecedent:T5
T1	Drug 3783 3802	alcoholic beverages
T2	Drug 3753 3756	AHA
T4	Drug 3910 3914	iron
T5	Drug 3919 3922	AHA
T6	Drug 3499 3506	insulin
T7	Drug 44 47	AHA
T8	Drug 173 176	AHA
T9	Drug 288 291	AHA
T10	Drug 342 345	AHA
T11	Drug 546 549	AHA
T12	Drug 751 754	AHA
T13	Drug 866 869	AHA
T14	Drug 974 977	AHA
T15	Drug 1657 1660	AHA
T16	Drug 1822 1825	AHA
T17	Drug 2225 2228	AHA
T18	Drug 2268 2271	AHA
T19	Drug 3194 3197	AHA
T20	Drug 3462 3465	AHA
T21	Drug 3673 3676	AHA
T22	Drug 3852 3855	AHA
T23	Drug 4134 4137	AHA
T24	Drug 5037 5040	AHA
T25	Drug 5092 5095	AHA
T26	Drug 250 254	iron
T27	Drug 2345 2349	iron
T28	Drug 2496 2500	iron
T29	Drug 3886 3890	iron
T30	Drug 4010 4014	iron
T31	Drug 4058 4062	iron
T32	Drug_Class 358 367	inhibitor
T33	Drug_Class 2283 2292	inhibitor
T35	Drug 22 42	Acetohydroxamic acid
T98	SPAN 1 20	DESCRIPTION SECTION
T37	IndefiniteNP 52 80	a stable, synthetic compound
T38	PossessivePronoun 127 150	Its molecular structure
T39	DefiniteNP 256 276	The molecular weight
T40	IndefiniteNP 296 301	a pKa
T41	IndefiniteNP 314 329	a melting point
T42	IndefiniteNP 349 367	a urease inhibitor
T43	ZeroArticleNP 382 396	250 mg tablets
T44	ZeroArticleNP 468 486	adjunctive therapy
T45	PersonalPronoun 610 612	it
T46	IndefiniteNP 898 922	A patient package insert
T47	DistributiveNP 948 960	each patient
T48	ZeroArticleNP 1134 1166	appropriate antimicrobial agents
T49	ZeroArticleNP 1293 1335	culture-specific oral antimicrobial agents
T50	IndefiniteNP 1507 1528	a satisfactory method
T51	IndefiniteNP 1639 1655	a pregnant woman
T52	DefiniteNP 1931 1942	the patient
T53	DefiniteNP 1984 1995	the patient
T54	DefiniteNP 2018 2038	the potential hazard
T55	DefiniteNP 2042 2051	the fetus
T56	DemonstrativeNP 1889 1898	this drug
T57	DemonstrativeNP 1973 1982	this drug
T58	IndefiniteNP 2275 2292	a known inhibitor
T59	PossessivePronoun 2351 2385	Its bone marrow suppressant effect
T60	PossessivePronoun 2409 2420	its ability
T61	DefiniteNP 2518 2542	the only clinical effect
T62	IndefiniteNP 2574 2584	a decrease
T63	DefiniteNP 2753 2765	the platelet
T64	IndefiniteNP 2903 2930	a chloro-benzene derivative
T65	IndefiniteNP 2995 3013	an unrelated study
T66	DefiniteNP 3225 3236	the kidneys
T67	IndefiniteNP 3323 3334	a reduction
T68	ZeroArticleNP 3372 3399	excessive drug accumulation
T69	ZeroArticleNP 3435 3452	DRUG INTERACTIONS
T70	ZeroArticleNP 3545 3566	progestational agents
T71	IndefiniteNP 3727 3751	other therapeutic agents
T72	IndefiniteNP 3819 3825	a rash
T73	DefiniteNP 3892 3906	The absorption
T74	DefiniteNP 3928 3948	the intestinal lumen
T75	DistributiveNP 3969 3979	both drugs
T76	DefiniteNP 4075 4086	the product
T77	IndefiniteNP 4190 4195	a day
T78	IndefiniteNP 4199 4217	a total daily dose
T79	ZeroArticleNP 4169 4179	one tablet
T80	DefiniteNP 4238 4253	The recommended
T81	DefiniteNP 4335 4346	the stomach
T82	IndefiniteNP 4323 4329	a time
T83	DefiniteNP 4357 4379	The maximum daily dose
T84	DefiniteNP 4441 4451	The dosage
T85	DemonstrativeNP 4606 4619	such patients
T86	DefiniteNP 4697 4713	the accumulation
T87	DefiniteNP 4741 4750	the blood
T88	DefiniteNP 4826 4842	the optimum dose
T89	DefiniteNP 5042 5050	The risk
T90	DefiniteNP 5121 5132	the chances
T91	IndefiniteNP 5137 5156	a beneficial effect
T92	DemonstrativeNP 5160 5173	such patients
T93	IndefiniteNP 5187 5202	an initial dose
T94	DefiniteNP 5255 5266	the patient
T95	DefiniteNP 5340 5348	the dose
T96	DefiniteNP 5448 5456	the risk
T97	IndefiniteNP 5401 5430	an optimum therapeutic effect
